Qlaris Bio to Present Data on QLS-111 at 2025 Glaucoma Congress
23 Jun 2025 //
BUSINESSWIRE
Qlaris Develops Combo Therapy of QLS-111 With Latanoprost
11 Jun 2025 //
BUSINESSWIRE
Daré`s royalty deal; Qlaris Bio raises $24M
30 Apr 2024 //
ENDPTS
Qlaris Bio Reports Phase 2 Clinical Trial Results for QLS-101
18 May 2022 //
BUSINESSWIRE